Ceres Ventures Company Description
Ceres Ventures, Inc., a development stage company, focuses on the research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air.
Its technologies include BluFlow Nanoparticles, a proprietary system for formulating, producing, and deploying customizable absorbent nanoparticles to specific functionality for contaminant/chemical removal and extraction of valuable elements and compounds from water based solutions; BluFlow Advanced Ultrafiltration Technology, an automated process to recover water from waste or impure streams; and BluFlow Treatment System a water and wastewater treatment solution, which incorporates the BluFlow Nanoparticles and the BluFlow Advanced Ultrafiltration Technology to remove target elements, compounds, and pollutants, as well as purify water that may be suitable for reuse.
Ceres Ventures, Inc.’s products are used in water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and valuable elements and compounds extraction applications.
The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011.
Ceres Ventures, Inc. was founded in 2010 and is based in New York, New York.
| Country | United States |
| Founded | 2010 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
Contact Details
Address: 430 Park Avenue New York, Nevada 10022 United States | |
| Phone | 800-611-3388 |
Stock Details
| Ticker Symbol | CEVE |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US15677X1072 |
| SIC Code | 3569 |
Key Executives
| Name | Position |
|---|---|
| Frank J. Fabio | Interim Chief Financial Officer |